Targeting oncogenic signaling pathways, Lactobacillus rhamnosus and B. pseudolongum inhibit IL-6/STAT3 pathway activity by reducing IL-6 levels or enhancing STAT3 methylation, respectively, and thus blocking tumor cell growth and angiogenesis[162,165]. Here, IL6 is linked to neoplasm.